Literature DB >> 17332713

Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report.

Kazuhiro Honda1, Jin Nishimiya, Hideki Sato, Maki Munakata, Masaki Kamada, Akihide Iwamura, Hideaki Nemoto, Takashi Sakamoto, Tatsuhiko Yuasa.   

Abstract

Transient lesions at the splenium of the corpus callosum (SCC) have been reported after withdrawal of specific antiepileptic drugs (AED), though the pathophysiology of the lesions remains unclear. We examined and treated a schizophrenic patient who developed a transient SCC lesion after withdrawal of the AED, carbamazepine. Interestingly, the SCC lesion was accompanied by the onset of diabetes insipidus, a state of arginine-vasopressin (AVP) insufficiency. Because carbamazepine is shown to potentiate the effect of AVP, our case suggests that an insufficiency of AVP followed by withdrawal of AED could contribute to the pathogenesis of a transient SCC lesion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17332713     DOI: 10.2463/mrms.5.211

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  4 in total

Review 1.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

Review 2.  Patterns and variations in microvascular decompression for trigeminal neuralgia.

Authors:  Hiroki Toda; Masanori Goto; Koichi Iwasaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-04-28       Impact factor: 1.742

3.  Transient and reversible focal lesion involving the splenium of the corpus callosum in a person with epilepsy.

Authors:  Nitin C Parikh; Makarand Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

4.  Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.

Authors:  Chunrong Li; Xiujuan Wu; Hehe Qi; Yanwei Cheng; Bing Zhang; Hongwei Zhou; Xiaohong Lv; Kangding Liu; Hong-Liang Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.